Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gastric Cancer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 69 articles: HTML format

Single Articles

February 2026
1. YAO YH, Dou QX, Li SN, Liu L, et al
   Comment on "Scissor-Type Knife Improves Trainee's Self-Completion of Endoscopic Submucosal Dissection for Early Gastric Cancer".
   J Gastroenterol Hepatol. 2026 Feb 24. doi: 10.1111/jgh.70323.
   PubMed    
   
   
   
2. HUANG Y, Xie S, Yan C, Zhang J, et al
   Neutrophil-Mediated Mechanisms and Therapeutic Reversibility of Gastric Intestinal Metaplasia.
   J Gastroenterol Hepatol. 2026;41:586-605.
   PubMed     Abstract available
   
   
   January 2026
3. MA Y, Zhang Y, Hu X, Jiang Z, et al
   Identifying a Novel Six-LncRNA Signature Evaluates Survival and Reveals AC129507.1 as the m(6)A-Target to Regulate Ferroptosis in Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Jan 23. doi: 10.1111/jgh.70255.
   PubMed     Abstract available
   
   
   
4. UYAMA K, Iwagami H, Nakatani Y, Uenoyama Y, et al
   Large, White Globe Appearance-Like Endoscopic Findings: Stomach Lymphatic Invasion Distant From Advanced Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Jan 21. doi: 10.1111/jgh.70256.
   PubMed     Abstract available
   
   
   
5. FUKUI H, Dohi O, Iwai N, Seya M, et al
   Scissor-Type Knife Improves Trainee's Self-Completion of Endoscopic Submucosal Dissection for Early Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Jan 6. doi: 10.1111/jgh.70216.
   PubMed     Abstract available
   
   
   
6. LUO SB, Liu ZQ, Wang L, Zhang YQ, et al
   Feasibility and Safety of Endoscopic Full-Thickness Resection for Gastric Submucosal Tumors With Extraluminal Growth.
   J Gastroenterol Hepatol. 2026;41:260-267.
   PubMed     Abstract available
   
   
   
7. JIA Z, Xiong K, Zhou Y, Chen R, et al
   Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma.
   J Gastroenterol Hepatol. 2026;41:231-247.
   PubMed     Abstract available
   
   
   December 2025
8. ICHITA C, Kusano C, Gotoda T, Hagiwara Y, et al
   Prevalence and Incidence of Gastric Cancer Among Helicobacter pylori-Naive Individuals in Japan: A Systematic Review and Meta-Analysis.
   J Gastroenterol Hepatol. 2025 Dec 29. doi: 10.1111/jgh.70217.
   PubMed     Abstract available
   
   
   
9. CHIANG TH, Chuang SL, Chu TC, Lee YC, et al
   Population-Based Helicobacter pylori Screening for Gastric Cancer Prevention: Opportunities and Challenges in Asia.
   J Gastroenterol Hepatol. 2025 Dec 22. doi: 10.1111/jgh.70209.
   PubMed     Abstract available
   
   
   November 2025
10. DENG X, Hu Y, Yang X, Luo X, et al
    FTO Upregulates GLG1 Expression via m(6)A Methylation Modification to Facilitate Gastric Cancer Cell Migration and Invasion.
    J Gastroenterol Hepatol. 2025 Nov 24. doi: 10.1111/jgh.70170.
    PubMed     Abstract available
    
    
    
11. LIU G, Liu Y, Zhao H, Sun J, et al
    m6A-Modified BASP1 Regulates IL6 Expression to Induce TAM Infiltration to Promote Gastric Cancer Progression.
    J Gastroenterol Hepatol. 2025 Nov 18. doi: 10.1111/jgh.70149.
    PubMed     Abstract available
    
    
    
12. YAO YH, Wang ZH, Shen XJ, Liu L, et al
    Underwater Endoscopic Mucosal Resection for Early Gastric Cancer: An Endoscopic Treatment Method Worthy of Study.
    J Gastroenterol Hepatol. 2025 Nov 6. doi: 10.1111/jgh.70158.
    PubMed    
    
    
    October 2025
13. SHEN M, Cai Q, Wang R, Zhang F, et al
    Development and Validation of a New Prediction Criteria for Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer Based on Ferroptosis-Related Biomarkers.
    J Gastroenterol Hepatol. 2025 Oct 26. doi: 10.1111/jgh.70124.
    PubMed     Abstract available
    
    
    
14. AKAZAWA Y, Ueyama H, Nakamura S, Uemura Y, et al
    Usefulness of Automated Analysis System for Microvascular Blood Flow Rate Using Magnifying Endoscopy in Early Gastric Cancer: A Multicenter Retrospective Study (With Video).
    J Gastroenterol Hepatol. 2025 Oct 6. doi: 10.1111/jgh.70102.
    PubMed     Abstract available
    
    
    
15. ARIF S, Fatima R, Rana RUR
    Evaluating the Quality of Life in Gastric Cancer Survivors: Reflections on Jeon et al.'s Nationwide Study.
    J Gastroenterol Hepatol. 2025 Oct 4. doi: 10.1111/jgh.70108.
    PubMed    
    
    
    
16. JESWANI HK, Hassnain SF, Maheshwari S
    Letter to the Editor: Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study.
    J Gastroenterol Hepatol. 2025 Oct 2. doi: 10.1111/jgh.70103.
    PubMed    
    
    
    
17. VEERASATHIAN T, Rattanapitoon SK, Rattanapitoon NK
    Comment on "Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study".
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70106.
    PubMed    
    
    
    September 2025
18. ANDO Y, Uedo N, Tani Y, Ueda T, et al
    Usefulness of Underwater Endoscopic Mucosal Resection Compared With Conventional Endoscopic Mucosal Resection for Early Gastric Cancer.
    J Gastroenterol Hepatol. 2025 Sep 3. doi: 10.1111/jgh.70062.
    PubMed     Abstract available
    
    
    
19. ISHIDA T, Yamaguchi T, Yoshida T, Kobayashi S, et al
    Evaluating Malignant Potential of Gastric Adenomas: The Role of Endoscopic Features and Genetic Alterations.
    J Gastroenterol Hepatol. 2025;40:2282-2289.
    PubMed     Abstract available
    
    
    August 2025
20. JEON HJ, Choi HS, Lee JM, Kim ES, et al
    Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study.
    J Gastroenterol Hepatol. 2025 Aug 7. doi: 10.1111/jgh.70000.
    PubMed     Abstract available
    
    
    
21. IWASAKI M, Matsumura T, Okimoto K, Ohyama Y, et al
    Long-Term Outcomes of Gastric Subepithelial Lesion of < 2 cm and Risk Factors for Tumor Growth.
    J Gastroenterol Hepatol. 2025;40:1926-1932.
    PubMed     Abstract available
    
    
    July 2025
22. WAJEEHA FNU, Raza S, Toor Z
    Comments on Programmed Cell Death Signature and THBS1 in Gastric Cancer: Advancing Toward Translational Clarity.
    J Gastroenterol Hepatol. 2025 Jul 24. doi: 10.1111/jgh.70035.
    PubMed    
    
    
    June 2025
23. WANG J, Li D, Ye F, Li J, et al
    Global Epidemiology of Early-Onset Digestive System Malignancy: A Systematic Analysis for the Global Burden of Disease Study 2021.
    J Gastroenterol Hepatol. 2025;40:1525-1535.
    PubMed     Abstract available
    
    
    
24. ALI M, Srour L, Bitar M, Karam K, et al
    Current Guidelines and Advances in the Management of Fundic Gland Polyps.
    J Gastroenterol Hepatol. 2025;40:1374-1380.
    PubMed     Abstract available
    
    
    
25. XIE X, Su J, Wang W, Wei H, et al
    Trends in Stomach Cancer Burden in China: A Joinpoint and APC Analysis Based on GBD 2021.
    J Gastroenterol Hepatol. 2025;40:1500-1514.
    PubMed     Abstract available
    
    
    May 2025
26. SHIBATA H, Fujiyoshi T, Kawata N, Obayashi T, et al
    Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents.
    J Gastroenterol Hepatol. 2025 May 27. doi: 10.1111/jgh.17027.
    PubMed     Abstract available
    
    
    
27. YOUNG E, Wan N, Philpott H, Singh R, et al
    The West Catching Up With the East: High-Magnification NBI Is Accurate for the Diagnosis of Gastric Neoplasia in a Western Population.
    J Gastroenterol Hepatol. 2025;40:1128-1134.
    PubMed     Abstract available
    
    
    April 2025
28. WANG M, Guo Y, Xu Y, Yu Y, et al
    Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response.
    J Gastroenterol Hepatol. 2025 Apr 28. doi: 10.1111/jgh.16987.
    PubMed     Abstract available
    
    
    
29. PITTAYANON R, Tiankanon K, Faknak N, Lerttanatum N, et al
    Efficacy of Radiofrequency Ablation as a Treatment for High-Risk Gastric Intestinal Metaplasia: A Randomized, Self-Control Study.
    J Gastroenterol Hepatol. 2025;40:891-899.
    PubMed     Abstract available
    
    
    March 2025
30. 
    NOTIFICATION: MiR-876-3p Regulates Cisplatin Resistance and Stem Cell-like Properties of Gastric Cancer Cells by Targeting TMED3.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16919.
    PubMed    
    
    
    February 2025
31. HARA K, Kawara F, Yamanaka K, Nishioka C, et al
    Gastrointestinal: White Granules in the Stomach Caused by Lymphangitis Carcinomatosis From Signet-Ring Cell Gastric Carcinoma.
    J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1111/jgh.16894.
    PubMed    
    
    
    December 2024
32. HUANG L, Feng B, Yang Z, Feng ST, et al
    A Transfer Learning Radiomics Nomogram to Predict the Postoperative Recurrence of Advanced Gastric Cancer.
    J Gastroenterol Hepatol. 2024 Dec 27. doi: 10.1111/jgh.16863.
    PubMed     Abstract available
    
    
    
33. OTANI K, Hang DV, Pittayanon R, Liu H, et al
    Asia-Pacific Survey on the Management of Helicobacter pylori Infection.
    J Gastroenterol Hepatol. 2024 Dec 26. doi: 10.1111/jgh.16862.
    PubMed     Abstract available
    
    
    
34. MATSUEDA K, Kono Y, Miyahara K, Nakagawa M, et al
    Clinical Significance of Lymphatic Involvement in Intramucosal (pT1a) Gastric Cancer Resected by Endoscopic Submucosal Dissection.
    J Gastroenterol Hepatol. 2024 Dec 18. doi: 10.1111/jgh.16854.
    PubMed     Abstract available
    
    
    
35. PAKNESHAN S, Moy N, Shah A, Koloski N, et al
    Post-colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study.
    J Gastroenterol Hepatol. 2024;39:2811-2816.
    PubMed     Abstract available
    
    
    
36. HUANG L, Xu M, Li Y, Dong Z, et al
    Gastric neoplasm detection of computer-aided detection-assisted esophagogastroduodenoscopy changes with implement scenarios: a real-world study.
    J Gastroenterol Hepatol. 2024;39:2787-2795.
    PubMed     Abstract available
    
    
    
37. HIRATA S, Hamada K, Iwamuro M, Mouri H, et al
    Rates and risk factors of bleeding after gastric endoscopic submucosal dissection with continuous warfarin or 1-day withdrawal of direct oral anticoagulants.
    J Gastroenterol Hepatol. 2024;39:2760-2766.
    PubMed     Abstract available
    
    
    September 2024
38. DANPANICHKUL P, Auttapracha T, Kongarin S, Ponvilawan B, et al
    Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019.
    J Gastroenterol Hepatol. 2024;39:1856-1868.
    PubMed     Abstract available
    
    
    August 2024
39. ISHIBASHI F, Suzuki S, Kobayashi K, Tanaka R, et al
    Cost-effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16715.
    PubMed     Abstract available
    
    
    
40. HAYASAKA J, Hoteya S, Takazawa Y, Kikuchi D, et al
    Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.
    J Gastroenterol Hepatol. 2024;39:1580-1585.
    PubMed     Abstract available
    
    
    July 2024
41. CHANTAROJANASIRI T, Sonthalia N, Lui RN
    Small gastric subepithelial lesions: A sand in the eye.
    J Gastroenterol Hepatol. 2024;39:1207-1209.
    PubMed    
    
    
    
42. GENG ZH, Qu YF, Fu PY, Zhu Y, et al
    A scoring system to predict the technical difficulty of endoscopic resection for cardial submucosal tumors.
    J Gastroenterol Hepatol. 2024;39:1352-1357.
    PubMed     Abstract available
    
    
    
43. MIMURA T, Yamamoto Y, Suzuki H, Takizawa K, et al
    Risk factors for intraoperative and delayed perforation related with gastric endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2024;39:1358-1366.
    PubMed     Abstract available
    
    
    
44. FUJITA M, Yamaguchi K, Nagashima K, Suzuki K, et al
    Impact of the COVID-19 pandemic on gastric surgery in Japan: A nationwide study using interrupted time-series analyses.
    J Gastroenterol Hepatol. 2024;39:1277-1284.
    PubMed     Abstract available
    
    
    
45. KOBAYASHI R, Hirasawa K, Ozeki Y, Sawada A, et al
    Clinical course of small gastric subepithelial lesion less than 20 mm diagnosed by endoscopic ultrasound-guided fine-needle aspiration.
    J Gastroenterol Hepatol. 2024;39:1285-1290.
    PubMed     Abstract available
    
    
    
46. ZENG X, Yang L, Dong Z, Gong D, et al
    The effect of incorporating domain knowledge with deep learning in identifying benign and malignant gastric whitish lesions: A retrospective study.
    J Gastroenterol Hepatol. 2024;39:1343-1351.
    PubMed     Abstract available
    
    
    June 2024
47. LI M, He W, Wang F, Zhang P, et al
    High expression of NOTCH2 in gastric adenocarcinoma: A novel early diagnostic target.
    J Gastroenterol Hepatol. 2024;39:1115-1122.
    PubMed     Abstract available
    
    
    
48. CHEUNG KS
    Big data approach in the field of gastric and colorectal cancer research.
    J Gastroenterol Hepatol. 2024;39:1027-1032.
    PubMed     Abstract available
    
    
    
49. CHEN L, Jin T, Fang Y, Wu G, et al
    Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    J Gastroenterol Hepatol. 2024;39:1073-1081.
    PubMed     Abstract available
    
    
    May 2024
50. KAWAMURA M, Uedo N, Yao K, Koike T, et al
    Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    J Gastroenterol Hepatol. 2024 May 13. doi: 10.1111/jgh.16617.
    PubMed     Abstract available
    
    
    
51. CHO JH, Jin SY, Park S
    Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
    J Gastroenterol Hepatol. 2024;39:942-948.
    PubMed     Abstract available
    
    
    
52. TANI Y, Li JW, Uedo N
    Gastrointestinal: Texture and color enhancement imaging is useful for detection of small gastric adenocarcinoma of fundic-gland type.
    J Gastroenterol Hepatol. 2024;39:783-784.
    PubMed    
    
    
    April 2024
53. ASONUMA S, Hatta W, Koike T, Okata H, et al
    Risk stratification of synchronous gastric cancers including alcohol-related genetic polymorphisms.
    J Gastroenterol Hepatol. 2024 Apr 16. doi: 10.1111/jgh.16570.
    PubMed     Abstract available
    
    
    
54. ZHAN ZQ, Chen YZ, Huang ZM, Luo YH, et al
    Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
    J Gastroenterol Hepatol. 2024;39:630-641.
    PubMed     Abstract available
    
    
    
55. WANG Z, He D, Yang JL
    Gastrointestinal: Chronic anemia caused by diffuse lesions of the stomach.
    J Gastroenterol Hepatol. 2024;39:615-616.
    PubMed    
    
    
    March 2024
56. GU L, Wang X, Ouyang M, Li F, et al
    Facilitating endoscopic full-thickness resection for gastric submucosal tumors with a novel snare traction method (with video).
    J Gastroenterol Hepatol. 2024;39:535-543.
    PubMed     Abstract available
    
    
    November 2023
57. DONG X, Chen X, Zhao Y, Wu Q, et al
    CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
    J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1111/jgh.16402.
    PubMed     Abstract available
    
    
    
58. TANAKA K, Baba Y
    Gastrointestinal: Diminutive Epstein-Barr virus-associated gastric carcinoma.
    J Gastroenterol Hepatol. 2023 Nov 16. doi: 10.1111/jgh.16410.
    PubMed    
    
    
    October 2023
59. MATSUEDA K, Uedo N, Kitamura M, Shichijo S, et al
    Endoscopic features of gastric neuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2023;38:1808-1817.
    PubMed     Abstract available
    
    
    
60. JUNG YS, Tran MTX, Park B, Moon CM, et al
    Mutual association between family history of gastric and colorectal cancer and risk of gastric and colorectal cancer.
    J Gastroenterol Hepatol. 2023;38:1787-1793.
    PubMed     Abstract available
    
    
    September 2023
61. QUEK SXZ, Lee JWJ, Feng Z, Soh MM, et al
    Comparing artificial intelligence to humans for endoscopic diagnosis of gastric neoplasia: An external validation study.
    J Gastroenterol Hepatol. 2023;38:1587-1591.
    PubMed     Abstract available
    
    
    August 2023
62. ZHANG P, Xu T, Wang J, Li Y, et al
    Comparison of different risk stratifications for gastric cancer and establishing a simplified risk-scoring model based on the Kyoto classification.
    J Gastroenterol Hepatol. 2023 Aug 24. doi: 10.1111/jgh.16324.
    PubMed     Abstract available
    
    
    June 2023
63. KAWASAKI K, Torisu T, Esaki M, Eizuka M, et al
    Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesions: A propensity score matched study.
    J Gastroenterol Hepatol. 2023;38:955-961.
    PubMed     Abstract available
    
    
    
64. LIU J, Xiang Y, Tang D, Xu G, et al
    Gastrointestinal: A case of type 1 gastric neuroendocrine tumor with multiple endocrine neoplasia type 1.
    J Gastroenterol Hepatol. 2023;38:842.
    PubMed    
    
    
    May 2023
65. TANAKA T, Miwa K, Shimotsuura Y, Nagasu S, et al
    High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
    J Gastroenterol Hepatol. 2023 May 24. doi: 10.1111/jgh.16239.
    PubMed     Abstract available
    
    
    
66. HIGASHINO M, Ono S, Matsumoto S, Kubo M, et al
    Improvement of detection sensitivity of upper gastrointestinal epithelial neoplasia in linked color imaging based on data of eye tracking.
    J Gastroenterol Hepatol. 2023;38:710-715.
    PubMed     Abstract available
    
    
    April 2023
67. CHEN N, Hu Y, Huang RZ, Chen DL, et al
    Circular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by regulating ZEB2.
    J Gastroenterol Hepatol. 2023 Apr 20. doi: 10.1111/jgh.16189.
    PubMed     Abstract available
    
    
    March 2023
68. NIE X, Zhao C, Zhang Y, Huang W, et al
    Nucleolar protein TCOF1 maintains gastric cancer cell proliferation by regulating R-loop associated DNA replication stress.
    J Gastroenterol Hepatol. 2023 Mar 20. doi: 10.1111/jgh.16181.
    PubMed     Abstract available
    
    
    
69. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum